New painkiller could ease recovery after lung surgery
NCT ID NCT06529432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a long-acting painkiller (bupivacaine liposome) injected near the spine to control pain after lung surgery. About 96 adults having a specific type of lung surgery will receive either the new drug or a standard painkiller. The goal is to see if the new drug provides better pain relief with fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCAL ANALGESIA VIA NERVE BLOCK are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Hospital Affiliated to Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China